Key result
Female sex linked to ~21% lower mortality after TAVR despite more bleeding and vascular events.
Why the study?
There has been conflicting clinical evidence regarding the influence of female sex on outcomes after transcatheter aortic valve replacement.
Does female sex influence mortality and safety outcomes in patients undergoing transcatheter aortic valve replacement?
Population
11,310 patients after transcatheter aortic valve replacement across 5 studies
Comparison
Female vs male sex
Design
Collaborative meta-analysis of individual patient-level data
Follow-up
Median 387 days
Authors
Loading...
Women may benefit from TAVR despite higher complications; extends prior RCTs via patient-level meta-analysis.
Meta-Analysis (n=11,310)
Yes
Does female sex influence mortality and safety outcomes in patients undergoing transcatheter aortic valve replacement?
Hazard Ratio: 0.79 (95% CI 0.73–0.86)
p-value: p=0.001
Female sex is an independent predictor of late survival after TAVR, despite higher early rates of bleeding, vascular, and stroke complications.
O’Connor et al. (2015) conducted a meta-analysis in transcatheter aortic valve replacement (n=11,310). Female sex vs. Male sex was evaluated on all-cause mortality (adjusted HR 0.79, 95% CI 0.73 to 0.86, p=0.001). Female sex was independently associated with improved survival after transcatheter aortic valve replacement (adjusted HR 0.79; 95% CI 0.73-0.86; p=0.001), despite more bleeding and vascular events.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: